AB

Alexander Birkmann

AA Aicuris Anti-Infective Cures Ag: 6 patents #2 of 48Top 5%
AK Aicuris Gmbh & Co. Kg: 5 patents #17 of 145Top 15%
📍 Wuppertal, DE: #189 of 1,656 inventorsTop 15%
Overall (All Time): #444,450 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12152022 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof Yogeshwar BACHHAV, Wilfried Schwab, Kurt Voegtli 2024-11-26
12070451 Sulfate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof Yogeshwar BACHHAV, Wilfried Schwab, Susanne BONSMANN, Thomas GOLDNER 2024-08-27
RE49697 Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Wilfried Schwab, Kerstin Paulus, Kurt Vogtli, Dieter Haag, Stephan Maas +1 more 2023-10-17
11266636 Maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof for the treatment of herpes viruses Yogeshwar BACHHAV, Wilfried Schwab, Susanne BONSMANN, Thomas GOLDNER 2022-03-08
11213516 Intravaginally applicable devices comprising antiviral compounds Yogeshwar BACHHAV, Susanne BONSMANN, Tamara Pfaff, Karl Malcolm 2022-01-04
11021474 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof Yogeshwar BACHHAV, Wilfried Schwab, Kurt Voegtli 2021-06-01
10137117 Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Wilfried Schwab, Kerstin Paulus, Kurt Vogtli, Dieter Haag, Stephan Maas +1 more 2018-11-27
9889124 Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Wilfried Schwab, Kerstin Paulus, Kurt Vogtli, Dieter Haag, Stephan Maas +1 more 2018-02-13
9592225 Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Wilfried Schwab, Kerstin Paulus, Kurt Vogtli, Dieter Haag, Stephan Maas +1 more 2017-03-14
9340535 N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate Wilfried Schwab, Kurt Vogtli, Dieter Haag, Andreas Lender, Alfons Grunenberg +2 more 2016-05-17
9119786 Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations Wilfried Schwab, Kerstin Paulus, Kurt Vogtli, Dieter Haag, Stephan Maas +1 more 2015-09-01